Real-World Evidence for Regulatory Success
As Real-World Data (RWD) becomes increasingly integrated into the medical device lifecycle, organizations have new opportunities to generate evidence that informs regulatory decision-making, strengthens submissions, and supports patient access. This Forum Pillar explores the frameworks, methodologies, and collaborative approaches advancing the use of Real-World Evidence (RWE) across MedTech.
Harnessing the Power of Real-World Evidence
Real-World Evidence (RWE) is transforming how medical devices are evaluated, approved, and adopted. This Forum Pillar explores how organizations are leveraging high-quality Real-World Data (RWD), integrated evidence strategies, and collaborative partnerships to strengthen regulatory decision-making, reduce development risk, and improve patient outcomes.
Join regulators, manufacturers, healthcare providers, patient organizations, researchers, and technology partners as we examine emerging methodologies, implementation strategies, and case studies that are advancing regulatory science.
Bring Your Expertise to the Forum Stage
For our Real-World Evidence for Regulatory Success Pillar, we are seeking session proposals that include—but are not limited to—the following themes:
- Operationalizing Data-Driven Advancement
- Trailblazing Evidence Pathways
- Building Trust through RWD
- Emerging Practices in Evidence Generation
- Case Studies in Regulatory Success
Submission Details
Accepted presenters receive a complimentary registration to the Innovators Forum.
EARLY DECISION DEADLINE: August 7, 2026 | Questions? Info@MDIC.org
August 7, 2026
Early decision deadline
March 1–4, 2027
MDIC Innovators Forum in Hyattsville, Maryland
Advancing Real-World Evidence
Data Quality
Explore approaches and frameworks that strengthen the quality, reliability, and fitness of Real-World Data for regulatory use.
Evidence Generation
Share innovative methodologies and practical strategies for generating meaningful, fit-for-purpose evidence.
Regulatory Impact
Demonstrate how Real-World Evidence is informing regulatory decisions and accelerating patient access to innovative technologies.